Strategically speaking; institutional investors from the previous capital raising with risk free options would best be served by limiting the issuance of new shares in HyAct ACL (therefore higher ACL share price now) then pushing down the share price of HyAct ACL prior to conversion, to maximize the number of shares they are entitled too.
- Forums
- ASX - By Stock
- the attractivesness of acl
Strategically speaking; institutional investors from the...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable